Literature DB >> 7559278

Clinical features, management, and outcome of patients with severe asthma admitted to the intensive care unit.

E R Pacht1, S Lingo, R C St John.   

Abstract

The objective of this study was to retrospectively review the medical records of 38 consecutive admissions to the medical intensive care unit of a tertiary-care university hospital of patients with severe asthma, and to determine the clinical characteristics of these patients, treatment regimens, and ultimate outcome. The 38 patients presented with severe asthma accompanied by hypoxemia, hypercapnia (mean pCO2 of 54.3 +/- 4.5 mm Hg), and decreased peak flow rates (125.5 +/- 12.4 L/min). The patients spent a mean of 60.1 +/- 9.7 hr in the medical intensive care unit. Seventeen of the 38 patients required intubation and mechanical ventilation. Overall, there were no deaths or significant complications. All 38 patients were discharged from the hospital. We conclude that severe, life-threatening asthma can be appropriately managed in the medical intensive care unit with a low incidence of complications and death. Prolonged mechanical ventilation is rarely required and most patients respond while the relatively simple management strategies.

Entities:  

Mesh:

Year:  1995        PMID: 7559278     DOI: 10.3109/02770909509082762

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  3 in total

Review 1.  Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  L Fabbri; B Beghé; G Caramori; A Papi; M Saetta
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

2.  Ten years of asthma admissions to adult critical care units in England and Wales.

Authors:  Ben Gibbison; Kathryn Griggs; Mome Mukherjee; Aziz Sheikh
Journal:  BMJ Open       Date:  2013-09-19       Impact factor: 2.692

3.  Outcome of patients with severe asthma in the intensive care unit.

Authors:  Abdulaziz Alzeer; Ahmed BaHammam; Mohammed Masood; Sayed Jani Basha; Esam Alhamad; Sayed Sohail
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.